Comparison Chart Intensity Therapeutics, Inc.
Stocks
INTS
US45828J2024
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:30:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 3.280 USD | -0.30% |
|
-7.61% | -68.02% |
| 08-11 | Intensity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Intensity Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -0.30% | -7.61% | -68.02% | -52.91% | - | 10.74M |  |  | |
- Stock Market
- Stocks
- INTS Stock
- Charts Intensity Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
